BlueLinx Holdings BXC Specialty products — Cost of Sales

Other product segments

Similar metrics at other companies

BCPCSpecialty Products — Cost of Sales

$14.26M-10.8%

LKQSpecialty — Cost of goods sold

$310M+3.7%

GTLSSpecialty Products — Cost of Sales

$168.8M-12.3%

PRGOSpecialty Care — Cost of Sales

$92.8M+13.0%

AMRXSpecialty — Cost of goods sold

$43.02M-19.0%

SCLSpecialty Products — Cost of Goods Sold

$15.17M+45.9%

Questions, answered.

What is BlueLinx Holdings's specialty products — cost of sales?

BlueLinx Holdings (BXC) reported specialty products — cost of sales of $419.24M in Q1 2026.

How has BlueLinx Holdings's specialty products — cost of sales changed year-over-year?

BlueLinx Holdings's specialty products — cost of sales increased by 7.6% year-over-year, from $389.61M to $419.24M.

What is the long-term trend for BlueLinx Holdings's specialty products — cost of sales?

Over 3 years (2022 to 2025), BlueLinx Holdings's specialty products — cost of sales has grown at a -9.0% compound annual growth rate (CAGR), from $2.23B to $1.68B.

What does specialty products — cost of sales mean?

This metric captures the direct costs attributable to the production or procurement of specialty building products sold during the reporting period, including inventory acquisition and inbound logistics. It is a critical component for calculating the gross margin of the specialty segment and evaluating supply chain efficiency. Monitoring these costs provides insight into the company's ability to manage commodity price volatility and maintain profitability within its specialty product lines.